肌萎缩侧索硬化临床试验招募信息（全球在招）

这里汇总了全球正在招募患者的 肌萎缩侧索硬化（国际通用名 amyotrophic lateral sclerosis）新药临床试验，包含试验分期、招募状态、开展国家和研究团队联系方式，全部以中文呈现。数据实时来自全球最大的临床试验注册库 ClinicalTrials.gov。本页同时覆盖渐冻症、渐冻人、ALS、运动神经元病等说法。

正在招募的肌萎缩侧索硬化新药试验

• The Swedish BioFINDER 2 Study

  不适用招募中SwedenNCT03174938

• Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Amisodin in Healthy Adult Subjects With Amyotrophic Lateral Sclerosis

  I 期招募中美国NCT07221240

• Expression Profile Study of Macrophages From Patients Affected by ALS or Other Related Motor Impairments

  不适用招募中法国NCT04816227

• Impairments of Neuro-muscular Communication in Motor-Neuron Disease: A Bio-Marker for Early and Personalised Diagnosis

  不适用招募中IrelandNCT05663008

• Evaluating Verbal Communication in Structured Interactions: Theoretical and Clinical Implications

  不适用招募中美国NCT06266403

• Anticipated Patient and Caregiver Burden

  不适用招募中法国NCT05632757

• Plasmapheresis in Amyotrophic Lateral Sclerosis With Autoantibody Against NRIP 2 (PALADIN2)

  不适用招募中中国台湾NCT07726563

• Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS

  III 期招募中美国Belgium加拿大法国NCT07322003

• Creation of a Clinical Database for the Study of Phenotypic Variability in Motor Neuron Diseases

  不适用招募中意大利NCT06318585

• Advances in Telephone-based Cognitive Screening Procedures

  不适用招募中意大利NCT06337578

• Discovery and Validation of Protein Structural Complexes in Circulating Biofluids As Novel Biomarkers for Early Diagnosis, Prognosis and Therapeutic Management of Patients Affected by Neurodegenerative Disorders

  不适用招募中意大利NCT06803784

• Investigation on the Cortical Communication (CortiCom) System

  不适用招募中美国NCT03567213